the aid library

LIST OPTIONS

Filter

15199

Sexuelle und geschlechtsspezifische Gewalt gegen Flüchtlinge, RückkehrerInnen und Binnenvertriebene: Richtlinien zur Vorbeugung und Reaktion

UNHCR (2003) CC

Die Erfahrung zeigt, dass sexülle und geschlechtsspezifische Gewalt vorallem dort ein verbreitetes Phänomen ist, wo die Menschenrechte generellmissachtet werden. Sexülle und geschlechtsspezifische Gewalt ist zweifellos an sich eine Menschenrechtsverletzung. Fraün und Kinder, die dem Risiko, Opfe... more

External Link

Hospital safety Index Guide for Evaluators. Forms

World Health Organization WHO World Health Organization and Pan American Health Organization (2015) C_WHO

checklist

Download (479)

View PDF (494)

FAQs: Waste Management for COVID-19 in Healthcare Settings for Africa
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

Health care waste can be difficult to treat and dispose of safely. The environmental and health impacts of waste put extra pressure on resources. Therefore, it is important to try and reduce the quantities of waste wherever possible. Ensure waste is segregated properly at the point of disposal. It i... more

Download (706)

View PDF (754)

Lineamientos técnicos para el abordaje integral, multidisciplinario e interinstitucional a las personas con pie diabético

José, F.; C G. Alvarenga Cardoza, K.M. Díaz de Naves Ministerio de Salud El Salvador (2021) C1

Technical guidelines for a comprehensive, multidisciplinary and inter-institutional approach to people with diabetic neuropathy

Download (468)

View PDF (368)

Inter-Agency Reproductive Health Kits 6th Edition - Manual

Inter-Agency Working Group on Reproductive Health in Crisis IAWG and UNFPA (2021) C1

Download (312)

View PDF (326)

National Antenatal Sentinel HIV Survey Key Findings, South Africa 2017

south (2019) CC

Download (405)

View PDF (341)

Bénin (Indice des composantes du programme maternel et néonatal)

MNPI (2003) C2

Chaque année dans le monde, plus de 500 000 femmes et filles meurent suite aux complications imputables à la grossesse et à l’accouchement. Plus de 99% de ces décès surviennent dans des pays comme le Bénin. Et pourtant les décès maternels ne racontent qu’une partie de la vérité. En e... more

Download (380)

View PDF (426)

PLANO DE CONTINGÊNCIA COVID-19 (Nivel 3 - EEXECUÇÃO)

Ministério da Saúde, Brasil (2022) C1

Download (367)

View PDF (397)

Mental Health in the times of COVID-19 Pandemic

National Institute of Mental Health & Neurosciences, Bengaluru India; Dept. of Psychiatry (2020) CC

Guidance for General Medical and Specialised Mental Health Care Settings

Download (274)

View PDF (310)

Venezuela: Plan de Respuesta Humanitaria con Panorama de Necesidades 2020

Office for the Coordination of Humanitarian Affairs OCHA (2020) CC

El Plan de Respuesta Humanitaria con Panorama de Necesidades Humanitarias Venezuela 2020 tiene por objeto proporcionar asistencia humanitaria a 4,5 millones de venezolanos y venezolanas vulnerables. Para ello, hace un llamado de $762,5 millones de dólares. El Plan se basa en la labor humanitaria qu... more

Download (514)

View PDF (882)

Appel Éclair: Plan de Réponse d'urgence - République Démocratique du Congo, Région des Kasai

United Nations Office for the Coordination of Humanitarian Affairs (2017) C1

Download (302)

View PDF (584)

Reflection on inclusive health services in northwest Syria (NWS)

Islamic Relief (2022) CC

After a decade of crisis, Syria remains one of the world’s most complex humanitarian crises. Continued hostilities, new and protracted displacement, increased returns and the sustained destruction of communities have impacted Syrians’ lives and futures in a devastating way. The 2021 Humanitarian... more

Download (309)

View PDF (567)

Recomendaciones para el tratamiento hospitalario de la COVID-19 en pacientes adultos ( Version 10, 2020)

G, Zambrano, E Salgato, F. M. Moyano et al. (2020) CC

Recommendations for in-patient management of COVID-19 in adult patients Version 10, November 2020.

Download (513)

View PDF (733)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1410)

View PDF (3275)

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India + Annexures

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare (2012) C1

Download (633)

View PDF (797)

Epidemic meningitis surveillance in the African meningitis belt

World Health Organization WHO (2014) C_WHO

This document is intended to serve as a reference for national public health policy-makers. It outlines the scope of potential meningitis surveillance strategies that make it possible to obtain the data required for epidemic detection, monitoring of epidemiological and microbiological trends, evalua... more

Download (641)

View PDF (909)

Knowledge, Attitudes and Practice surveys Zika virus disease and potential complications. Resource pack

World Health Organization (2016) C_WHO

This is a resource pack for a Knowledge, Attitudes and Practices (KAP) surveys about Zika virus and its suspected complications such as microcephaly and Guillain-Barré syndrome. This resource and associated advice was requested by governments and response partners as a way to rapidly obtain valuab... more

Download (2276)

View PDF (2161)

WHO Safe Childbirth Checklist Implementation Guide
recommended

World Health Organization WHO (2015) C_WHO

This implementation guide has been developed to help birth attendants and health-care leaders successfully launch and sustain use of the WHO Safe Childbirth Checklist. Development, use and implementation of the Checklist are described in this guide. It covers how to introduce and ensure continuous ... more